Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases PR Newswire Nawigacja wpisu Study shows role of cells’ own RNA in antiviral defense – UW Medicine Newsroom Oncodesign Precision Medicine Reacquires Rights to Its OPM-201 Program From Servier After a Positive Phase I Trial in Healthy Volunteers – Business Wire
